Use Via Early Access to Ixazomib (UVEA-IXA) Study: Effectiveness and Safety of Ixazomib-based Therapy in Relapsed/Refractory Multiple Myeloma Outside of the Clinical Trial Setting.
Saved in:
| Title: | Use Via Early Access to Ixazomib (UVEA-IXA) Study: Effectiveness and Safety of Ixazomib-based Therapy in Relapsed/Refractory Multiple Myeloma Outside of the Clinical Trial Setting. |
|---|---|
| Authors: | Ludwig H; First Department of Medicine, Wilhelminen Cancer Research Institute, Center for Oncology and Hematology, Clinic Ottakring, Vienna, Austria. Electronic address: heinz.ludwig@extern.gesundheitsverbund.at., Ramasamy K; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Mateos MV; Department of Hematology, University Hospital of Salamanca, IBSAL, CIC, IBMCC (USAL-CSIC), Salamanca, Spain., Kishore B; Heart of England/University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Gergely V; Faculty of Medicine Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary., Ladicka M; National Cancer Institute, Bratislava, Slovakia., Ori A; MediNeos, Observational Research, Modena, Italy., Simoni L; MediNeos, Observational Research, Modena, Italy., Bent-Ennakhil N; Takeda Pharmaceuticals International AG, Zurich, Switzerland., Stull DM; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA., Gavini F; Takeda Pharmaceuticals International AG, Zurich, Switzerland., Terpos E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece., Hájek R; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic; Department of Haematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. |
| Source: | Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Feb; Vol. 24 (2), pp. e40-e49.e3. Date of Electronic Publication: 2023 Oct 14. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2152-2669 |
|---|---|
| DOI: | 10.1016/j.clml.2023.10.003 |
